SELLAS Life Sciences Group
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Times Sq Ste 2503, New York, New York,...Phone Number
(646) 200-5278Website
www.sellaslifesciences.comRevenue
<$5 MillionStock Symbol
SLSIndustry
About SELLAS Life Sciences Group
SELLAS Life Sciences Group is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies and therapeutics for a broad range of cancer indications. The Company's lead product candidate, galinpepimut-S, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets a broad spectrum of hematologic cancers and solid tumor indications. SELLAS is headquartered in New York, NY.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SLSShow moreSELLAS Life Sciences Group Org Chart
Compare Similar Companies to SELLAS Life Sciences Group
Compare insights from companies similar to SELLAS Life Sciences Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SELLAS Life Sciences Group Tech Stack
A closer look at the technologies used by SELLAS Life Sciences Group
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SELLAS Life Sciences Group
Sign Up For FreeTo access detailed company insights
SELLAS Life Sciences Group is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies and therapeutics for a broad range of cancer indications. The Company's lead product candidate, galinpepimut-S, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets a broad... Read More